Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population

Blood Pressure

Volumn 19, Issue 2, 2010, Pages 67-74

  Mazza, Alberto ^a,b   Zamboni, Sergio ^a   Rubello, Domenico ^a   Schiavon, Laura ^a   Zorzan, Sara ^a   Casiglia, Edoardo ^b  

^a General Hospital of Rovigo   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Arterial hypertension; Chronic obstructive pulmonary disease; Elderly; Mortality

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; SEX DIFFERENCE; CARDIOVASCULAR DISEASES; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR;

AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 77950603467     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037050903464642     Document Type: Article

References (53)

1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al.. Chronic obstructive pulmonary disease: Current burden and future projections. Eur Respir J. 2006;27:397-412.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
3. Antonelli-Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:2794-2800.
4. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128:2005-2011.
5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, et al.. 2007 ESH-ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187. (Pubitemid 46924065)
6. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068-2075.
7. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, et al.. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63-70.
8. Ryan G, Knuiman MW, Divitini ML, James A, Musk AW, Bartholomew HC. Decline in lung function and mortality: The Busselton health Study. J Epidem Com Health. 1999; 53:230-234.
9. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. Copd. 2005;2:35-41.
10. Casiglia E, Spolaore P, Mormino P, Maschio O, Colangeli G, Celegon L, et al..; The CASTEL project (CArdiovascular STudy in the ELderly): Protocol, study design, and preliminary results of the initial survey. Cardiologia. 1991;36: 569-576.
11. Cherniack RM, Raber MB. Normal standards for ventilator function using an automated wedge spirometer. Am Rev Resp Dis. 1972;106:38-46.
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77-S121.
13. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al.. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995;8:1398-1420.
14. Ledru F, Ducimetiere P, Battaglia S, Courbon D, Beverelli F, Guize L, et al.. New diagnostic criteria for diabetes and coronary artery disease: Insights from an angiographic study. J Am Coll Cardiol. 2001;37:1543-1550.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
16. Nicoll SR, Sainsbury R, Bailey RR, King A, Frampton C, Elliot JR, Turner JG. Assessment of creatinine clearance in healthy subjects over 65 years of age. Nephron1991;59: 621-625.
17. Mazza A, Casiglia E, Scarpa R, Pessina AC. Prognostic value of proteinuria in elderly subjects with normal renal function. High Blood Press. 1997;6:1-7.
18. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classifi cation. Littleton, MA: John Wright-PSG Inc.; 1982.
19. Cox DR. Regression models and life tables. J Roy Statist Soc 34, Series B. 1972;187-220.
20. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic infl ammation in chronic obstructive pulmonary disease. Circulation. 2003; 107:1514-1519.
21. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: A populationbased study and a systematic review of the literature. Chest. 2005;127:1952-1959.
22. Ross R. Atherosclerosis: An infl ammatory disease. N Engl J Med. 1999;340:115-126.
23. Schwarcz TH, Hogan LA, Endean ED, Roitman IT, Kazmers A, Hyde GL. Thromboembolic complications of polycythemia: Polycythemia vera versus smokers polycythemia. J Vasc Surg. 1993;17:518-522.
24. Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005;128:1201-1208.
25. Plywaczewski R, Silwinski P, Nowinski A, Kaminski D, Zielinski J. Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy. Chest. 2000;117:679-683.
26. Chaouat A, Weitzenblum E, Kessler R, Schott R, Charpentier C, Levi-Valensi P, et al.. Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation. Eur Resp J. 2001;17:848-855.
27. Coccagna G, Pollini A, Provini F. Cardiovascular disorders and obstructive sleep apnea syndrome. Clin Exp Hypertens. 2006;28:217-224
28. Sin DD, Man SF. Systemic infl ammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol. 2007;85:141-147.
29. de Kruif MD, van Gorp EC, Keller TT, Ossewaarde JM, ten Cate H. Chlamydia pneumoniae infections in mouse models: Relevance for atherosclerosis research. Cardiovasc Res. 2005; 65:317-327.
30. Casiglia E, Tikhonoff V. Infl ammatory and coagulative markers of atherosclerosis. Eur Heart J. 2007;28:271-273.
31. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax. 2006;61: 849-853.
32. Dhungel S, Paudel B, Shah S. Study of prevalence of hypertension in chronic obstructive pulmonary disease patients admitted at Nepal Medical College and Teaching Hospital. Nepal Med Coll J. 2005;7:90-92.
33. Mazza A, Pessina AC, Tikhonoff V, Pavei A, Privato G, Casiglia E. Pulse pressure: An independent predictor of coronary and stroke mortality in elderly females from the general population. Blood Pressure. 2001;10:205-211.
34. Casiglia E, Tikhonoff V, Mazza A, Piccoli A, Pessina AC. Pulse pressure and coronary mortality in elderly men and women from general population. J Hum Hypert. 2002;15:611-620.
35. Mazza A, Zamboni S, Tikhonoff V, Scarpa R, Cuppini S, Zennaro R, et al.. Pulse hypertension: A new component of the metabolic syndrome in elderly women? J Hum Hypert. 2007;14:1-8.
36. Swaminathan RV, Alexander KP. Pulse pressure and vascular risk in the elderly: Associations and clinical implications. Am J Geriatr Cardiol. 2006;15:226-232.
37. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, et al.. Increased arterial stiffness in patients with chronic obstructive pulmonary disease; A mechanism for increased cardiovascular risk. Thorax. 2008;63:306-311.
38. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefi t of lowering blood pressure in hypertensive patients according to the JNC VI risk stratifi cation. Hypertension. 2000;35:539-543.
39. Pessina AC, Casiglia E. Are hypertensive patients undertreated? Aging Health. 2006;1:355-357.
40. Hoffman C, Rice D, Sung HY. Persons with chronic conditions: Their prevalence and costs. J Am Med Assoc. 1995; 276:1473-1479.
41. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: The Women's Health and Aging Study. J Clin Epidemiol. 1999;52:27-37. (Pubitemid 29064271)
42. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a populationbased study in the elderly. Am J Hypertens. 1997;10:697-704.
43. Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin P, Hume A, et al.. Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. Arch Intern Med. 1998;158:2377-2385.
44. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
45. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, et al.. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005;46:273-279.
46. Wolff JL, Starfi eld B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-2276.
47. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Gao X, Borbas C, et al.. The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med. 1997;12:1-6.
48. Aram V. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al.. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report. JAMA. 2003;289:2560-2572.
49. Fletcher C, Peto R. The natural history of chronic airfl ow obstruction. Br Med J. 1977;1:1645-1648.
50. Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A. Smoking cessation, decline in pulmonary function and total mortality: A 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax. 2001;56:703-707.
51. Rennard SI. Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease. Proc Am Thorac Soc. 2005;2:94-100.
52. Retta TM, Randall OS. Hypertension and concomitant diseases: A guide for evidence-based therapy. J Natl Med Assoc. 2004;96:450-460.
53. Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation. 2007;116:2992-3005.